Skip to main content
Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men
Published Web Location
http://europepmc.org/articles/PMC3956614?pdf=renderNo data is associated with this publication.
Abstract
Background: In addition to protecting against HIV acquisition, antiretroviral preexposure prophylaxis (PrEP) using topical 1% tenofovir gel reduced Herpes simplex virus type 2 (HSV-2) acquisition by 51% among women in the CAPRISA 004 study. We examined the
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.